These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


405 related items for PubMed ID: 31203669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK, Takeda K, Topkara VK, Takayama H, Garan AR, Yuzefpolskaya M, Colombo P, Naka Y, Farr M.
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [Abstract] [Full Text] [Related]

  • 6. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L, Hickey G, Keebler ME, Mathier MA, Sultan I, Gleason TG, Wang Y, Kilic A.
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.
    Arnaoutakis GJ, George TJ, Kilic A, Beaty CA, Weiss ES, Conte JV, Shah AS.
    Ann Thorac Surg; 2012 May; 93(5):1549-54; discussion 1555. PubMed ID: 22429670
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.
    Truby LK, Garan AR, Givens RC, Takeda K, Takayama H, Trinh PN, Yuzefpolskaya M, Farr MA, Naka Y, Colombo PC, Topkara VK.
    Circ Heart Fail; 2018 Apr; 11(4):e004586. PubMed ID: 29666073
    [Abstract] [Full Text] [Related]

  • 18. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM, Ising MS, Trivedi JR, Slaughter MS, Cheng A.
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [Abstract] [Full Text] [Related]

  • 19. Survival After Orthotopic Heart Transplantation in Patients Undergoing Bridge to Transplantation With the HeartWare HVAD Versus the Heartmate II.
    Magruder JT, Grimm JC, Crawford TC, Tedford RJ, Russell SD, Sciortino CM, Whitman GJR, Shah AS.
    Ann Thorac Surg; 2017 May; 103(5):1505-1511. PubMed ID: 27765177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.